Our cancer researchers are investigating the molecular basis of the disease including sarcoma, melanoma, mesothelioma, breast cancer, colorectal cancer, prostate cancer and biliary tract cancer. Many of these cancers are currently incurable.
Using model systems, protein and DNA-based technologies and imaging, they are developing new approaches and therapeutic targets to improve clinical diagnosis and treatment. A close relationship with the Olivia Newton-John Cancer Research Institute enhances bench-to-bedside outcomes.
To understand the molecular mechanisms of cancer, including processes that lead to abnormal cell growth and the ways in which cancer cells communicate with their surrounding environment to promote disease progression.
To identify new treatment strategies with improved efficacy and fewer side effects.
To develop new technologies for imaging and monitoring cancer progression, and to identify new biomarkers for diagnostic purposes.